Effects of caloric restriction on the gut microbiome are linked with immune senescence

Julia Sbierski-Kind, Sophia Grenkowitz, Stephan Schlickeiser, Arvid Sandforth, Marie Friedrich, Désirée Kunkel, Rainer Glauben, Sebastian Brachs, Knut Mai, Andrea Thürmer, Aleksandar Radonić, Oliver Drechsel, Peter J Turnbaugh, Jordan E Bisanz, Hans-Dieter Volk, Joachim Spranger, Reiner Jumpertz von Schwartzenberg, Julia Sbierski-Kind, Sophia Grenkowitz, Stephan Schlickeiser, Arvid Sandforth, Marie Friedrich, Désirée Kunkel, Rainer Glauben, Sebastian Brachs, Knut Mai, Andrea Thürmer, Aleksandar Radonić, Oliver Drechsel, Peter J Turnbaugh, Jordan E Bisanz, Hans-Dieter Volk, Joachim Spranger, Reiner Jumpertz von Schwartzenberg

Abstract

Background: Caloric restriction can delay the development of metabolic diseases ranging from insulin resistance to type 2 diabetes and is linked to both changes in the composition and metabolic function of the gut microbiota and immunological consequences. However, the interaction between dietary intake, the microbiome, and the immune system remains poorly described.

Results: We transplanted the gut microbiota from an obese female before (AdLib) and after (CalRes) an 8-week very-low-calorie diet (800 kcal/day) into germ-free mice. We used 16S rRNA sequencing to evaluate taxa with differential abundance between the AdLib- and CalRes-microbiota recipients and single-cell multidimensional mass cytometry to define immune signatures in murine colon, liver, and spleen. Recipients of the CalRes sample exhibited overall higher alpha diversity and restructuring of the gut microbiota with decreased abundance of several microbial taxa (e.g., Clostridium ramosum, Hungatella hathewayi, Alistipi obesi). Transplantation of CalRes-microbiota into mice decreased their body fat accumulation and improved glucose tolerance compared to AdLib-microbiota recipients. Finally, the CalRes-associated microbiota reduced the levels of intestinal effector memory CD8+ T cells, intestinal memory B cells, and hepatic effector memory CD4+ and CD8+ T cells.

Conclusion: Caloric restriction shapes the gut microbiome which can improve metabolic health and may induce a shift towards the naïve T and B cell compartment and, thus, delay immune senescence. Understanding the role of the gut microbiome as mediator of beneficial effects of low calorie diets on inflammation and metabolism may enhance the development of new therapeutic treatment options for metabolic diseases.

Trial registration: NCT01105143 , "Effects of negative energy balance on muscle mass regulation," registered 16 April 2010. Video Abstract.

Keywords: Adaptive immune system; Caloric restriction; Gut microbiota; Immune senescence; Obesity.

Conflict of interest statement

The authors have no conflict of interest to declare.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Caloric restriction changes the gut microbiome composition in humanized gnotobiotic mice. A Number of observed amplicon sequence variants (ASVs) and Shannon index indicate microbial richness and diversity for 3 weeks following colonization. P-values are given for repeated measures non-parametric ANOVA-type testing for differences between groups and time points (n = 104 stool samples across 23 mice and 5 time points). B Principal coordinates of Bray-Curtis dissimilarity between stool samples. Color indicates groups. Numeric labels denote the 5 time points. Ellipses enclose group masses (99% CI) for day 21. P-values are given for adonis permutational analysis of variance testing for group × time differences. C Heatmap representation of day 21 differentially abundant ASVs (n = 20). ASVs are shown at the most specific assigned taxonomy with FDR-adjusted P-values < 0.01 in DESeq2 two-sided Wald test. Bubbles indicate log-fold change (LFC) between the two groups. Heatmap colors indicate relative abundances as variance-stabilizing (log2) transformed counts ranging from 4 (dark blue, corresponding to 0 raw counts) to 14 (yellow, corresponding to 14K raw counts). Color of bubbles and species labels denote phylum. Bubble sizes are proportional to − log10 FDR-adjusted P-values. Dendrogram leaf numbers indicate individual housing cages
Fig. 2
Fig. 2
Colonization with CalRes-associated gut microbiota alters body fat and glucose clearance. Metabolic analysis of germ-free (GF) mice and mice inoculated with AdLib and CalRes human gut microbiota. A–C Spleen (A), epigonadal white adipose tissue (eWAT) (B), and liver (C) weights from GF and colonized mice. D Feces weight was measured using bomb calorimetry in GF and colonized mice. E Caecum weights from GF and colonized mice were analyzed with and without fecal contents. F Fasting male adult GF or colonized mice maintained on normal chow diet were challenged with oral glucose and blood was sampled for glucose at times indicated. G Area under the OGTT glucose-time curve (AUC). * P < 0.05, ** P < 0.01, **** P < 0.0001 as determined using ANOVA with Bonferonni’s post-test correction for multiple comparisons; error bars = SEM; ns = not significant
Fig. 3
Fig. 3
The CalRes microbiota reduces levels of intestinal effector memory CD8+ T cells and memory B cells. A, B The heatmaps show cluster phenotypes based on the expression of canonical lineage markers on pre-gated TCRß+ T cells (A) and on pre-gated TCRß−CD19−NK1.1− innate immune cells (B). The differential expression of each selected surface marker (rows) is shown for each immune cell cluster (columns). The significance levels of the comparison between the three mouse groups for each immune cell cluster are depicted by semi-supervised hierarchical clustering. The top bubbles denote clusters with significantly different abundances between the three groups. Bubble colors indicate one of the two groups being compared with higher average cellular frequencies; bubble size indicates the -log2 FDR-adjusted p-values. C Relative proportions of CD4+ (left panel) and CD8+ (right panel) naïve (Tnaïve, CD44−CD62L+), central memory (TCM, CD44+CD62L+), effector memory (TEM, CD44+CD62L−) and terminally differentiated effector memory T cells (TEMRA, CD44−CD62L−) measured by mass cytometry. T cell populations were manually gated according to established lineage markers. D–H Relative proportions of total B cells (D), naïve B cells (E), “switched” memory B cells (F), NK cells (G) and activated CD62L+CD11b+ NK cells (H). n = 9 or more mice per group. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 as determined using Student’s t-test or Mann-Whitney test, dependent on the distribution of the data
Fig. 4
Fig. 4
Colonization with human gut microbiota induces alterations of splenic immune cell subsets. A, B The heatmaps show the distribution of splenic immune lineages based on the expression of canonical lineage markers by t-SNE on pre-gated TCRß+ T cells (A) and on pre-gated TCRß−CD19−NK1.1− innate immune cells (B). The differential expression of each selected surface marker (rows) is shown for each immune cell cluster (columns). The significance levels of the comparison between the three mouse groups for each immune cell cluster are depicted by semi-supervised hierarchical clustering. The top bubbles denote clusters with significantly different abundances between the three groups. Bubble colors indicate one of the two groups being compared with higher average cellular frequencies; bubble size indicates the − log2 FDR-adjusted P-values. C Relative proportions of CD4+ (left panel) and CD8+ (right panel) naïve (Tnaïve, CD44−CD62L+), central memory (TCM, CD44+CD62L+), effector memory (TEM, CD44+CD62L−) and terminally differentiated effector memory T cells (TEMRA, CD44−CD62L−) measured by mass cytometry. T cell populations were manually gated according to established lineage markers. DH Relative proportions of B cells (D), naïve B cells (E), “switched” memory B cells (F), NK cells (G), and activated CD62L+CD11b+ NK cells (H). n = 9 or more mice per group. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 as determined using Student’s t-test or Mann-Whitney test, dependent on the distribution of the data
Fig. 5
Fig. 5
Caloric restriction-associated gut microbiota reduces levels of hepatic effector memory CD4+ and CD8+ T cells. A, B The heatmaps show the distribution of hepatic immune lineages based on the expression of canonical lineage markers by t-SNE on pre-gated TCRß+ T cells (A) and on pre-gated TCRß−CD19−NK1.1− innate immune cells (B). The differential expression of each selected surface marker (rows) is shown for each immune cell cluster (columns). The significance levels of the comparison between the three mouse groups for each immune cell cluster are depicted by semi-supervised hierarchical clustering. The top bubbles denote clusters with significantly different abundances between the three groups. Bubble colors indicate the one of the two groups being compared with higher average cellular frequencies; bubble size indicates the − log2 FDR-adjusted p-values. C Relative proportions of CD4+ (left panel) and CD8+ (right panel) naïve (Tnaïve, CD44−CD62L+), central memory (TCM, CD44+CD62L+), effector memory (TEM, CD44+CD62L−) and terminally differentiated effector memory T cells (TEMRA, CD44−CD62L−) measured by mass cytometry. T cell populations were manually gated according to established lineage markers. D–H Relative proportions of B cells (D), naïve B cells (E), “switched” memory B cells (F), NK cells (G), and activated CD62L+CD11b+ NK cells (H). n = 9 or more mice per group. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 as determined using Student’s t-test or Mann-Whitney test, dependent on the distribution of the data
Fig. 6
Fig. 6
Immunologic changes correlate with gut microbial alterations. Heatmaps show latent correlation matrices between abundances of amplicon sequence variants (ASVs) detected in stool samples and all immune parameters analyzed in colon (A) and spleen (B) of mice 21 days after inoculation with AdLib and CalRes human gut microbiota. Immune parameters are expressed as frequencies, i.e., percent of parent, except those labeled # which were quantified as absolute cell counts. Heatmaps were ordered according to rows and columns first principal components to highlight cross-correlation structures. Asterisks indicate variables that were selected in L1-penalized sparse canonical correlation analysis (CCA). Circular chord plots display latent correlation between frequencies of manually defined immune subsets and L1-selected ASVs including the top ten taxa that either positively (upper) or negatively (lower) associate with the immunological dataset. Blue to red color scale in heatmaps and chords indicates negative and positive correlation values. Color of row-legend bar and species labels denotes the phylum level. Colors of column legend bars indicate parental lineage and differentiation level (antigen-experience) of lymphocyte subsets, respectively. Boxplot insets show how experimental groups as a latent variable are explained by the canonical covariate

References

    1. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell. 2004;116(2):337–350. doi: 10.1016/S0092-8674(03)01081-X.
    1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9(1):88. doi: 10.1186/1471-2458-9-88.
    1. Akil L, Ahmad HA. Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved. 2011;22(4 Suppl):61–72. doi: 10.1353/hpu.2011.0166.
    1. Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887. doi: 10.1038/nature05488.
    1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579–591. doi: 10.1038/nrc1408.
    1. Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914–920. doi: 10.1038/nm.1964.
    1. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17(5):610–617. doi: 10.1038/nm.2353.
    1. Onodera T, Fukuhara A, Jang MH, et al. Adipose tissue macrophages induce PPARγ-high FOXP3+ regulatory T cells. Sci Rep. 2015;5(1):16801. doi: 10.1038/srep16801.
    1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801. doi: 10.1172/JCI29069.
    1. Exley MA, Hand L, O’Shea D, Lynch L. Interplay between the immune system and adipose tissue in obesity. J Endocrinol. 2014;223(2):R41–8. 10.1530/JOE-13-0516.
    1. Sbierski-Kind J, Mai K, Kath J, et al. Association between subcutaneous adipose tissue inflammation, insulin resistance, and calorie restriction in obese females. J Immunol. 2020;205(1):45–55. doi: 10.4049/jimmunol.2000108.
    1. McLaughlin T, Liu L-F, Lamendola C, et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol. 2014;34(12):2637–2643. doi: 10.1161/ATVBAHA.114.304636.
    1. Fabbrini E, Cella M, McCartney SA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology. 2013;145(2):366–74.e743. doi: 10.1053/j.gastro.2013.04.010.
    1. Messaoudi I, Warner J, Fischer M, et al. Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci. 2006;103(51):19448 LP–19419453. doi: 10.1073/pnas.0606661103.
    1. White MJ, Beaver CM, Goodier MR, et al. Calorie restriction attenuates terminal differentiation of immune cells. Front Immunol. 2017;7:667. doi: 10.3389/fimmu.2016.00667.
    1. Molinaro A, Caesar R, Holm LM, Tremaroli V, Cani PD, Bäckhed F. Host-microbiota interaction induces bi-phasic inflammation and glucose intolerance in mice. Mol Metab. 2017;6(11):1371–1380. doi: 10.1016/j.molmet.2017.08.016.
    1. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi: 10.1038/nature05414.
    1. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–484. doi: 10.1038/nature07540.
    1. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99–103. doi: 10.1038/nature12198.
    1. Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi: 10.1038/nature11450.
    1. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi: 10.1038/4441022a.
    1. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070 LP–11011075. doi: 10.1073/pnas.0504978102.
    1. Basolo A, Hohenadel M, Ang QY, et al. Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans. Nat Med. 2020;26(4):589–598. doi: 10.1038/s41591-020-0801-z.
    1. Carmody RN, Gerber GK, Luevano JM, Jr, et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2015;17(1):72–84. doi: 10.1016/j.chom.2014.11.010.
    1. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323. doi: 10.1038/nri2515.
    1. Ivanov II, Frutos R d L, Manel N, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4(4):337–349. doi: 10.1016/j.chom.2008.09.009.
    1. Geva-Zatorsky N, Sefik E, Kua L, et al. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168(5):928–943.e11. doi: 10.1016/j.cell.2017.01.022.
    1. Carmody RN, Bisanz JE, Bowen BP, et al. Cooking shapes the structure and function of the gut microbiome. Nat Microbiol. 2019;4(12):2052–2063. doi: 10.1038/s41564-019-0569-4.
    1. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3(4):213–223. doi: 10.1016/j.chom.2008.02.015.
    1. Jumpertz R, Le DS, Turnbaugh PJ, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr. 2011;94(1):58–65. doi: 10.3945/ajcn.110.010132.
    1. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–563. doi: 10.1038/nature12820.
    1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007;449(7164):804–810. doi: 10.1038/nature06244.
    1. Spranger L, Bredow J, Zeitz U, et al. Thrifty energy phenotype predicts weight regain - results of a randomized controlled trial. medRxiv. Published online January. 2021:2021.03.25.21254300. 10.1101/2021.03.25.21254300.
    1. von Schwartzenberg RJ, Bisanz JE, Lyalina S, et al. Caloric restriction disrupts the microbiota and colonization resistance. Nature. 2021;595(7866):272–277. doi: 10.1038/s41586-021-03663-4.
    1. Prehn K, Jumpertz von Schwartzenberg R, Mai K, et al. Caloric Restriction in Older Adults—Differential Effects of Weight Loss and Reduced Weight on Brain Structure and Function. Cereb Cortex. 2017;27(3):1765–1778. doi: 10.1093/cercor/bhw008.
    1. Mai K, Li L, Wiegand S, et al. An integrated understanding of the molecular mechanisms of how adipose tissue metabolism affects long-term body weight maintenance. Diabetes. 2019;68(1):57 LP–57 65. doi: 10.2337/db18-0440.
    1. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114–2120. doi: 10.1093/bioinformatics/btu170.
    1. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi: 10.1038/nmeth.3869.
    1. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261 LP–5265267. doi: 10.1128/AEM.00062-07.
    1. McMurdie PJ, Holmes S. phyloseq: An R Package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8(4):e61217. doi: 10.1371/journal.pone.0061217.
    1. Sbierski-Kind J, Kath J, Brachs S, et al. Distinct housing conditions reveal a major impact of adaptive immunity on the course of obesity-induced type 2 diabetes. Front Immunol. 2018;9(MAY). 10.3389/fimmu.2018.01069.
    1. Glauben R, Batra A, Fedke I, et al. Histone Hyperacetylation is associated with amelioration of experimental colitis in mice. J Immunol. 2006;176(8):5015 LP–5015022. doi: 10.4049/jimmunol.176.8.5015.
    1. Japp AS, Hoffmann K, Schlickeiser S, et al. Wild immunology assessed by multidimensional mass cytometry. Cytom Part A. 2017;91(1):85–95. doi: 10.1002/cyto.a.22906.
    1. Kotecha N, Krutzik PO, Irish JM. Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom. 2010;Chapter 10:Unit10.17. doi: 10.1002/0471142956.cy1017s53.
    1. Noguchi K, Gel YR, Brunner E, Konietschke F. nparLD: An R Software Package for the Nonparametric Analysis of Longitudinal Data in Factorial Experiments. J Stat Softw. 2012;50(12):1–23. 10.18637/jss.v050.i12.
    1. Nowicka M, Krieg C, Weber LM, et al. CyTOF workflow : differential discovery in high-throughput high-dimensional cytometry datasets [ version 2 ; peer review : 2 approved ] Referee Status. F1000Research. 2019;6(748):1–69.
    1. Fan J, Liu H, Ning Y, Zou H. High dimensional semiparametric latent graphical model for mixed data. J R Stat Soc Ser B Statistical Methodol. 2017;79(2):405–421. doi: 10.1111/rssb.12168.
    1. Frost F, Storck LJ, Kacprowski T, et al. A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: a pilot study. PLoS One. 2019;14(7):e0219489. doi: 10.1371/journal.pone.0219489.
    1. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1(6):6ra14. doi: 10.1126/scitranslmed.3000322.
    1. Kasai C, Sugimoto K, Moritani I, et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015;15(1):100. doi: 10.1186/s12876-015-0330-2.
    1. Clarke SF, Murphy EF, O’Sullivan O, et al. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One. 2013;8(6):e65790. doi: 10.1371/journal.pone.0065790.
    1. Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68(1):70–82. doi: 10.1136/gutjnl-2018-316103.
    1. Woting A, Pfeiffer N, Loh G, Klaus S, Blaut M. Promotes high-fat diet-induced obesity in gnotobiotic mouse models. Clemente Maria Gloria Dominguez JB, ed. MBio. 2014;5(5):e01530–e01514. doi: 10.1128/mBio.01530-14.
    1. Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi: 10.1038/s41579-020-0433-9.
    1. Crovesy L, Masterson D, Rosado EL. Profile of the gut microbiota of adults with obesity: a systematic review. Eur J Clin Nutr. 2020;74(9):1251–1262. doi: 10.1038/s41430-020-0607-6.
    1. Peters BA, Shapiro JA, Church TR, et al. A taxonomic signature of obesity in a large study of American adults. Sci Rep. 2018;8(1):9749. doi: 10.1038/s41598-018-28126-1.
    1. Méndez-Salazar EO, Ortiz-López MG, Granados-Silvestre M d LA, Palacios-González B, Menjivar M. Altered gut microbiota and compositional changes in Firmicutes and Proteobacteria in Mexican undernourished and obese children. Front Microbiol. 2018;9:2494. doi: 10.3389/fmicb.2018.02494.
    1. Kim CC, Healey GR, Kelly WJ, et al. Genomic insights from Monoglobus pectinilyticus: a pectin-degrading specialist bacterium in the human colon. ISME J. 2019;13(6):1437–1456. doi: 10.1038/s41396-019-0363-6.
    1. van Passel MWJ, Kant R, Zoetendal EG, et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One. 2011;6(3):e16876. doi: 10.1371/journal.pone.0016876.
    1. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7(3):189–200. doi: 10.1080/19490976.2015.1134082.
    1. Zarrinpar A, Chaix A, Xu ZZ, et al. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat Commun. 2018;9(1):2872. doi: 10.1038/s41467-018-05336-9.
    1. Claus SP, Ellero SL, Berger B, et al. Colonization-induced host-gut microbial metabolic interaction. MBio. 2011;2(2):e00271. doi: 10.1128/mBio.00271-10.
    1. Clinthorne JF, Beli E, Duriancik DM, Gardner EM. NK Cell maturation and function in C57BL/6 mice are altered by caloric restriction. J Immunol. 2013;190(2):712 LP–712722. doi: 10.4049/jimmunol.1201837.
    1. Zou H, Wang D, Ren H, et al. Effect of caloric restriction on BMI, gut microbiota, and blood amino acid levels in non-obese adults. Nutr. 2020;12(3). 10.3390/nu12030631.
    1. Dhakal S, McCormack L, Dey M. Association of the gut microbiota with weight-loss response within a retail weight-management program. Microorg. 2020;8(8). 10.3390/microorganisms8081246.
    1. Newman TM, Shively CA, Register TC, et al. Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model. Microbiome. 2021;9(1):100. doi: 10.1186/s40168-021-01069-y.
    1. Jaagura M, Viiard E, Karu-Lavits K, Adamberg K. Low-carbohydrate high-fat weight reduction diet induces changes in human gut microbiota. Microbiologyopen. 2021;10(3):e1194. doi: 10.1002/mbo3.1194.
    1. Ott B, Skurk T, Hastreiter L, et al. Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women. Sci Rep. 2017;7(1):11955. doi: 10.1038/s41598-017-12109-9.
    1. Del Chierico F, Nobili V, Vernocchi P, et al. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology. 2017;65(2):451–464. doi: 10.1002/hep.28572.
    1. Muralidharan J, Moreno-Indias I, Bulló M, et al. Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus Study. Am J Clin Nutr. 2021;114(3):1148–1158. doi: 10.1093/ajcn/nqab150.
    1. Maifeld A, Bartolomaeus H, Löber U, et al. Fasting alters the gut microbiome reducing blood pressure and body weight in metabolic syndrome patients. Nat Commun. 2021;12(1):1970. doi: 10.1038/s41467-021-22097-0.
    1. Xia X, Wu WKK, Wong SH, et al. Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 2020;8(1):108. doi: 10.1186/s40168-020-00847-4.
    1. Wirbel J, Pyl PT, Kartal E, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679–689. doi: 10.1038/s41591-019-0406-6.
    1. Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science (80- ) 2018;359(6371):97 LP–97103. doi: 10.1126/science.aan4236.
    1. Derosa L, Routy B, Fidelle M, et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur Urol. 2020;78(2):195–206. doi: 10.1016/j.eururo.2020.04.044.
    1. Nagayama M, Yano T, Atarashi K, et al. TH1 cell-inducing Escherichia coli strain identified from the small intestinal mucosa of patients with Crohn’s disease. Gut Microbes. 2020;12(1):1788898. doi: 10.1080/19490976.2020.1788898.
    1. Fouladi F, Glenny EM, Bulik-Sullivan EC, et al. Sequence variant analysis reveals poor correlations in microbial taxonomic abundance between humans and mice after gnotobiotic transfer. ISME J. 2020;14(7):1809–1820. doi: 10.1038/s41396-020-0645-z.
    1. Bisanz JE, Soto-Perez P, Noecker C, et al. A genomic toolkit for the mechanistic dissection of intractable human gut bacteria. Cell Host Microbe. 2020;27(6):1001–1013.e9. doi: 10.1016/j.chom.2020.04.006.

Source: PubMed

3
Se inscrever